Clinical Trial Update: 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing FLOT vs ECF regimens in locally advanced, resectable gastric cancer has completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• ECF (Epirubicin, Cisplatin, 5-FU)
• FLOT (5-FU, Leucovorin, Oxaliplatin, Docetaxel)

Snippet

Sponsor: Krankenhaus Nordwest | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: COMPLETED